Bicak, UgurKarabiber, HamzaOzerol, Halil I.Aslan, MehmetIlhan, AtillaYakinci, Cengiz2024-08-042024-08-0420080883-07381708-8283https://doi.org/10.1177/0883073808318052https://hdl.handle.net/11616/94678Our aim was to determine the levels of human urotensin-II (hU-II) in the plasma of migraine patients and controls, to ascertain if there were a difference in the pathogenesis of migraine. A total of 27 patients who suffer from migraines and 27 controls were included in the study. Venous blood samples were drawn twice both from migraine patients and controls to measure hU-II plasma levels. The average levels of hU-II during migraine episode, between episodes, and controls were found to be 0.483, 0.493, and 0.737 pg/mL, respectively The levels of hU-II in the controls were higher significantly. When comparisons were made according to sex, age groups, and types and durations of migraine, there was no significant difference in the levels of hU-II in the patients. The low levels of hU-II in the plasma of migraine patients compared with controls may be an indicator of its role in the pathogenesis.eninfo:eu-repo/semantics/closedAccessetiopathogenesismigraineurotensin IIArticle2311124912531898483210.1177/08830738083180522-s2.0-54549127456Q2WOS:000260505400001Q2